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ABSTRACT 
 
 
Hollyfield, Jennifer Lynne. M.S., Department of Biochemistry and Molecular Biology, 
Wright State University, 2009. Dose-dependent Effects of Oxygen on Metabolism in Rat 
Cortico-Hippocampal Brain Tissue Slices.  
 
 
   Studies have shown that 95% oxygen increases neuronal excitability and ROS 
production.  We wanted to investigate the dose-dependent effects of oxygen on brain 
slice metabolism.  We exposed rat brain cortico-hippocampal tissue slices to 0.40, 0.95, 
and 4.50 ATA O2 for 60 minutes, made dual-phase tissue extracts, and used multi-nuclear 
NMR experiments to elucidate the slice metabolism.  We found that low doses of oxygen 
may shift metabolism toward anaerobic glycolysis.  Elevated lactate suggests this shift, 
along with elevated ratios of NAD+/NADH which may drive the reactions toward the 
production of lactate.  The results also suggest that high doses of oxygen may cause 
aerobic glycolysis and oxidative phosphorylation to accelerate. Lower lactate amounts 
along with a low NAD+/NADH ratio may be driving these reactions towards pyruvate 
and the TCA cycle and suggest a highly oxidized environment.  The 0.40 ATA O2 results 
suggest a hypoxic environment while the 0.95 and 4.50 ATA O2 results suggest 
hyperoxic environments that lead to changes in metabolism on both ends of the oxygen 
spectrum.   
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Chapter I 
Introduction and Purpose 
 Chronic exposure to hypoxia or hyperoxia can yield great amounts of redox stress 
which can disrupt cellular and metabolic functions.  This is applicable in sleep apnea and 
ischemic reperfusion events such as stroke, heart attack, and hyperbaric oxygen therapy. 
In vitro tissue slice experiments were developed by Henry McIlwain in the 1950s.  Slices 
are sectioned while in an artificial cerebrospinal fluid (aCSF) and perfused with 95% 
oxygen and 5% CO2. Slice work has always been done at 95% oxygen so the core would 
not be anoxic.  Recent measurements of tissue slice partial pressures from Dr. Jay Dean’s 
laboratory have shown that, with the advent of thinner tissue slices, even the core is 
hyperoxic when exposed to 95% oxygen.  Electrophysiology experiments conducted in 
that lab also showed that neurons in the tissue slice have a more rapid firing rate.  ROS 
production is elevated when tissue slices are exposed to 95% O2. 
This research project was developed to determine the dose-dependent effects of 
oxygen on brain tissue metabolism to correlate with the electrophysiology results and the 
increase in ROS production results that were found in Dr. Jay Dean’s laboratory.  This 
will provide a profile of tissue metabolism and help to better understand the overall 
effects of O2 in these tissue slices.  No studies have shown the effects of hyperoxia on 
metabolism or pathways though.  This leads to the following hypotheses:  
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Hypothesis I:  High oxygen concentrations will cause a shift toward aerobic glycolysis 
and oxidative phosphorylation thereby perturbing the natural balance of the slice 
metabolism. 
Hypothesis II:  High oxygen concentrations will have a detrimental effect on lipid 
metabolism and phospholipid synthesis and degradation pathways compared to low 
oxygen concentrations due to increased ROS production.  
Investigation of these hypotheses will be done by: 
• Conducting rat brain slice experiments at 0.40, 0.95, and 4.50 ATA oxygen 
concentrations. 
• Extracting metabolites from brain slices using a dual-phase tissue extraction 
process. 
• Performing multi-nuclear NMR experiments on lipid and aqueous extracts. 
• Determining differences in small metabolites, phospholipids, and fatty acid and 
cholesterol lipid molecules between treatment groups. 
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Chapter II 
Background and Significance 
 
A. Oxygen and Oxidative Stress 
 
 Oxygen makes up about 21 percent of the air we breathe.  It is essential for most 
organisms to survive.  It is thought that the more oxygen there is in the air, the better. 
Hospitals will administer 100 percent oxygen to a patient when levels in the blood are 
low. This is at normobaric pressure, whereas high percentages of oxygen are also used 
when diving and for hyperbaric oxygen therapy (HBOT) but these are in pressurized 
environments.  Oxygen is not thought of as something that is dangerous or could be 
damaging within living systems. Recent studies have shown otherwise. 
 The brain tissue partial pressure of oxygen (PtiO2) measured in vivo of a mammal 
breathing room air at or near sea level (1 ATA) on average will range from about 3 Torr 
to 35 Torr, depending on the area of the brain. [1]  This is considered normoxic.  
Breathing pure O2 at sea level will cause the brain tissue partial pressure to increase to 
between 40 to 90 Torr. [2, 3] Hyperoxic is defined as a PtiO2 which is greater than 35 Torr 
and hypoxic is considered less than 3 Torr.  Not only is the concentration of oxygen 
important, but the length of time that the tissue is exposed has an additive effect.  The 
dose of oxygen is defined as the concentration of oxygen times the time exposed.   
Tissue slice work began back in the 1950s when Henry McIlwain developed the 
brain slice preparation. [4]  Slice work has since become an accepted technique.  But 
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slice work is conducted with a perfusate bubbled with 95% oxygen (0.95 ATA), which is 
considerably more than the 21% in ambient air.  This is considered normoxic, a control, 
for slice work and prevents the core of the slice, up to 700 μm thick, from becoming 
anoxic. [5]  It has been shown recently though that slices 300 to 400 um thick that are 
exposed to 0-15% oxygen renders a PtiO2 closer to what is measured in the normoxic 
intact brain than that in the hypoxic brain. [1]  Mulkey et al. showed that 95% oxygen 
causes a PtiO2 of 291 Torr even at the core. [6]  This is a 10-fold increase over in vivo and 
is hyperoxic.  Exposing brain slices to 3.3 ATA, which is a little greater than that used 
with HBOT, caused the core PtiO2 to rise to 1517 Torr, a 50-fold increase.  
 
B. Reactive Oxygen Species 
Reactive Oxygen Species (ROS) are molecules or ions that are highly reactive due 
to unpaired electrons in the valence shell.  They are the natural byproduct of oxygen 
metabolism, but when produced in excess can cause damage to surrounding cells.  
Superoxide anion, •O2–, is generated in the mitochodria, but overproduction can occur as 
a result of mitochondrial dysfunction. [7]  It has been shown that when tissue is exposed 
to hyperoxia that reactive oxygen species production increases [8] [9-12] including 
superoxide, hydrogen peroxide, hydroxyl radicals, nitric oxide, peroxynitrite, and 
associated intermediates. [9, 10, 12-16]   This results in oxidative stress because the 
increased amount of ROS may overwhelm antioxidants [17-19] and may have an effect 
on cellular and metabolic function. 
 Hyperbaric oxygen therapy (HBOT) also increases ROS production that can result 
in CNS toxicity, the symptoms of which include seizures, slow heart rate, increased 
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respiration, and shortness of breath. [20-24]  Even hyperoxia at normal pressures has 
been shown to have effects on neuronal excitability. [25-27] [28]  In electrophysiology 
experiments conducted in rat brain slices, hyperoxia increased the firing rate of neurons 
in medullary [29] and solitary complex neurons. [6]  These effects have been attributed to 
the oxidative effects of ROS. 
 A study exposing slices to 95% oxygen under normobaric pressures found a 
significant increase in compounds derived from the oxidation of docosahexanoic acid and 
suggested that the slices undergo a severe oxidative insult at this oxygen 
concentration.[11]  In a similar experiment, measurements of •O2– in CA1 neurons of rat 
hippocampal slices with dihydroethidium, which detects intracellular •O2– production, 
have shown that •O2– production was significantly increased in slices exposed to 95% O2 
at normobaric pressure as compared to 60, 40, and 20% O2. [30] That same experiment 
showed that the most cell death and increased excitability occurred when exposed to 95% 
O2 over the lower oxygen levels.  Hyperoxia will likely affect metabolism in the slice as 
well, but this has never been studied directly.   This is suggested by another study that 
compared slices exposed to hyperbaric oxygen with slices that had been metabolically 
poisoned. [6]  The higher the oxygen PO2 in the tissue the lower the tissue oxygen 
consumption. This was not different from the PO2 in tissue that had been metabolically 
poisoned with 2-deoxy-D glucose.  They suggested that high oxygen concentrations 
appeared to reduce metabolism. 
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C. Hippocampus    
 The CA1 region of the hippocampus is highly sensitive to changes in oxygen 
levels.  Hippocampal neurons are thought to play a role in seizure genesis during oxygen 
toxicity [17, 31] and other seizure-promoting conditions. [31-33]  There have been many 
studies on the effects of hypoxia and anoxia on the electrophysiology of these neurons, 
but few studies with hyperoxia. [34, 35] [31, 36]   It has been shown, though, that with 
acute exposure to hyperoxia, there is an increased firing rate and increased synaptic 
activity. [1, 34, 35]   
 
D. Nuclear Magnetic Resonance (NMR) 
 NMR is a very useful tool in examining changes in metabolic pathways across 
treatment groups (Figure 1).  Many different metabolites involved in glycolysis, energy 
metabolism, and lipid pathways can be examined in one experiment and amounts 
determined in tissue extracts.  It can examine synthesis and degradation pathways.  NMR 
experiments in our lab have been used to elucidate liver phospholipid biosynthesis with 
13C enrichments [37], look at the effects of hepatocarcinogens on liver phospholipid 
biosynthesis [38], and study phospholipid biosynthesis in brain before and after a toxic 
insult [39]. Chemical extracts of brain tissue slices can be prepared to separate lipid 
fractions and aqueous fractions.  Metabolic pathways that are affected by different 
oxygen concentrations can be elucidated by using a multi-nuclear approach of hydrogen 
(1H), phosphorus (31P) and carbon (13C), analysis of both the lipid and aqueous extracts of 
the brain tissue slices.  Aqueous extracts can reveal changes in energy metabolism by 
showing ATP levels, phosphocreatine (PCr), and inorganic phosphate (Pi).  Also, various 
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phosphomonoesters including phosphocholine (Pcho) and phosphoethanolamine (Petn) 
and phosphodiesters (glycerophosphocholine, GPC; and glycerophosphoethanolamine, 
GPE) that are important in phospholipid synthesis and degradation pathways can be 
examined.  Tissue viability can also be examined by measuring N-acetylaspartate (NAA), 
which is a neuronal marker.  Loss of NAA can show neuronal cell death. [40]  
Examination of the lipid extracts using 31P NMR can show changes in the phospholipid 
profile, including phosphatidylcholine and cardiolipin, which is an important 
mitochondrial membrane lipid.  The 13C lipid profile can provide information about free 
and esterified fatty acids and cholesterol levels and can elucidate changes in lipids, 
possible signaling pathways or membrane structure.  NMR is a useful tool to study the 
metabolic changes in brain slice tissue extracts to determine dose-dependent effects of 
oxygen of which has not been investigated.  
 
Dual Phase Tissue Extracts
Aqueous Lipid
1Hydrogen 31Phosphorous 31Phosphorous 13Carbon
Small Metabolites
•NAA
•Lactate
•Pyruvate
•Creatine
•Phosphocreatine
High Energy Phosphates
•ATP
•Phosphocreatine
•Inorganic Phosphate
•G3P
•DHAP
•Pcho
•Petn
•GPC
•GPE
Phospholipids
•PC
•Cho pls
•PI
•PS
•SM
•PE
•Etn pls
•CL
•PA
Lipids
•Cholesterol
•Triglycerides
•Omega-3 FA
•Saturated FA
Figure 1: Dual Phase Tissue Extracts
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Chapter III 
EXPERIMENTAL PROCEDURES 
 
A. Materials 
 Male Sprague-Dawley rats (40-42 days of age) were obtained from Harlan 
(Indianapolis, IN) and were housed at 22ºC with a 12-h light/dark cycle.  Rats were fed 
Harlan Teklad 22/5 rodent diet #8640.  All chemicals were reagent grade and purchased 
from standard sources. 
 
B. Experimental Protocol 
 Figure 2 depicts a timeline of the experimental protocol.  Rats were anesthetized 
using CO2 followed by decapitation.  Hippocampus with surrounding cortices was 
isolated and 400-µm-thick slices were cut sagittally with a Vibratome (series 1000) 
sectioning system (average 12 slices per animal).  Slices were incubated at room 
temperature for 1 hour with 95% O2-5% CO2 in artificial cerebrospinal fluid (aCSF) 
composed of (in mM): 5.0 KCl, 124 NaCl, 1.3 MgSO4, 26 NaHCO3, 1.24 KH2PO4, 10 
Glucose, and 2.4 CaCl2.  After this 1 h equilibration period, the slices were transferred to 
a two-sided perfusion container and placed inside a pressure chamber at 37°C. The 
perfusion medium consisted of aCSF equilibrated with one of the following gas mixtures 
for the specified time period:  95% O2-5% CO2 for 5 min. (Group 1); 95% O2-5% CO2 
for 60 min. (Group 2), 40% O2-5% CO2 for 60 min. (Group 3), or 98.5% O2-1.5% CO2 at 
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4.5 ATA for 60 min, (hyperbaric oxygen, Group 4).  Pressurization for hyperbaric 
oxygen group was less than 5 minutes; decompression for the same group was at that 
same rate.  At the completion of the experiment, slices were removed from the 
containers, rinsed in 0.9% saline, gathered into a strainer and blotted dry, then quickly 
frozen in liquid nitrogen (total time for this procedure was < 1 minute).  Tissue slices 
from 2 animals were combined to constitute 1 sample, with sample weights between 500 
and 700 mg, for analysis by NMR.  This was determined from preliminary experiments 
where approximately 24 tissue slices yielded sufficient sample for good signal-to-noise 
ratio in the various NMR experiments. 
 
Figure 2: Timeline of Experiments. 
 
C. Chemical Extract Preparation 
 Chemical extracts were prepared using a dual phase extraction method.  This 
method allows for extraction of an aqueous and a lipid phase simultaneously.  All 
solvents and homogenates were kept on ice during the entire procedure.  The brain slices 
were homogenized using a 40-ml glass homogenizer tube and Teflon pestle.  Slices were 
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first homogenized in methanol (MeOH), then chloroform (CHCL3) and water (1:1:1 
v/v/v, 0.7ml/100 mg tissue).  The homogenate was centrifuged at 2000 X g for 25 
minutes.  This separated the homogenate into 2 phases and a pellet.  The supernatant was 
then transferred to a separatory funnel through filter paper and the pellet was washed 3 
times with 0.5 ml of each extraction solvent, centrifuged for 5 minutes (2000 X g), and 
transferred to the same separatory funnel through the filter paper.  The sample was left to 
separate completely at 4°C for 17-24 hours.   
The sample was moved to room temperature to allow for further separation for 2 
hours.  The upper phase, containing the aqueous portion, was removed by aspiration into 
a lyophilizer flask and partially evaporated under a gentle nitrogen gas stream in a 25°C 
water bath to remove most of the MeOH.  The bottom phase containing the lipid was 
drained into a vial and evaporated to dryness under a gentle nitrogen gas stream in a 25°C 
water bath.  The separatory funnel was washed 3 times with 0.5 ml of each extraction 
solvent, allowed 45 minutes to separate, and transferred to the appropriate container for 
evaporation.  The aqueous phase was then frozen in the flask with liquid nitrogen and 
lyophilized to dryness overnight.  The lipid phase was placed on a vacuum overnight and 
weighed the next day to obtain total lipid content. The lipid sample was then stored in 0.6 
ml of deuterochloroform (CDCL3) at -15 °C. 
 
D. Preparation of NMR Samples 
 Dried extracts recovered from the aqueous phase were reconstituted in 2 ml of 
water with 0.1 g of Chelex 100 (removes divalent cations) and stirred for 2 hours at 4°C.  
The sample was transferred to a 15 ml disposable centrifuge tube and centrifuged for 10 
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minutes (2000 X g) at 4°C to remove the Chelex 100.  The supernatant was transferred to 
a vial.  The lyophilizer flask was rinsed with 2 ml of water 3 times, centrifuged, and 
transferred to the vial.  The vial was frozen in liquid nitrogen and lyophilized to dryness 
overnight.  The next day, the vial was weighed and the aqueous sample weight 
calculated.  The final dried aqueous extracts were reconstituted in 0.7 ml of deuterium 
oxide (D2O, 100%) and 0.603 ml of reconstituted sample transferred to a 5mm NMR 
tube.  A standard of trimethysilylpropionic (2,2,3,3 d4) acid (TSP; 0.43mM) was added 
for proton (1H) NMR.  Disodium ethylenediaminetetraacetic acid (Na2EDTA; 30.5 mM) 
and methylene diphosphonic acid (MDPA; 1.5 mM), a standard, were added for 
phosphorus (31P) NMR.    The final lipid extracts were prepared by transferring 0.5 ml of 
lipid sample (in CDCl3 solvent) to a 5mm NMR tube and mixing with 0.2 ml Cs2 (EDTA) 
in 1:4 D2O: MeOH.  Carbon (13C) and phosphorus (31P) NMR spectra were then acquired.  
 
E. NMR Experiments 
High-resolution 1H and proton-decoupled 31P and 13C NMR spectra of brain slice 
extracts were acquired using a Varian INOVA 600 NMR spectrometer (14.1 T) operating 
at 600.0, 242.79, and 150.82 MHz, respectively. The temperature was regulated at 25ºC 
for aqueous extracts and 20ºC for lipid extracts.  For 1H NMR, a presaturation pulse 
sequence was used to minimize the residual water signal.  Acquisition parameters 
included a sweep width of 9611.9 Hz, 2.5-second acquisition time, and 20-second 
interpulse delay for 256 transients.  Data acquisition parameters for 31P aqueous samples 
included a sweep width of 12121.2 Hz, 1.6-second acquisition time, and 3.6-second 
interpulse delay for 20,000 transients.  13C lipid acquisition parameters included a sweep 
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width of 34965 Hz, 1.3-second acquisition time, and 1.9-second interpulse delay for 
40,000 transients.  31P lipid data were acquired using a sweep width of 1074.4 Hz, 1.6-
second acquisition time, and a 10-second interpulse delay for 768 transients.     
The 1H data were processed using exponential multiplication (linebroadening of 
0.3 Hz), Fourier transformation, base line corrected using a 5th order polynomial and 
spline fit, and referenced to TSP set at 0.0 ppm.  The 31P aqueous and lipid data used a 
linebroadening of 1.0 Hz and referenced to phosphocreatine at 0.0 ppm and 
phosphatidylcholine at -0.84 ppm, respectfully.  13C lipid data used a linebroadening of 
0.5 Hz and referenced to MeOH at 49.9 ppm. 
 
Lactate Creatine
Phosphocreatine
Figure 3: Representative 1H aqueous spectrum from rat cortico-hippocampal brain tissue slices.
Lactate
N-acetylaspartate
Pyruvate
Acetate
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DHAP
Glycerol-3-Phosphate
Inorganic Phosphate
Phosphocreatine
ΒNTPs
DHAP
G-3-P
Inorganic Phosphate
hosphocreatine
β NTPs
Figure 4: Representative 31P aqueous spectrum from rat cortico-hippocampal brain tissue slices.
GPC
GPE
Pcho
Petn
 
 
Phosphatidic Acid
cardioliipin
Ethanolamine plasmologen
Phosphatidylethanolamine
Sphingomyelin
Phoshatidylserine
Phosphatiylinositol Choline plasmologen
Phosphatidylcholine
Phosphatid cid
Cardiolipin
Ethanolamine plasmalogen
Phosphatidylethanolamine
Sphingomyelin
Phosphatidylserine
Phosphatiylinositol
Choline plasmal en
Phosphatidylcholine
Figure 5: Representative 31P lipid spectrum from rat cortico-hippocampal brain tissue slices.
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Carbonyl carbons
C=O
Allylic carbons
C=C
Fatty acid  -CH3
CDCL3
Cholesterol C5
PC
TAG
ω-3 FA
Cholesterol C18
Figure 6: Representative 13C lipid spectrum from rat cortico-hippocampal brain tissue slices.
Aliphatic carbons
 
 
F.  1H Principle Component Analysis and Linear Discriminant Analysis 
Principle Component Analysis (PCA) is a “non-supervised” pattern recognition 
program that was used to analyze the 1H spectra only.  The groups are not identified so it 
looks for a pattern in the signal intensities of the dataset. The hope is that a group will 
have the same pattern depending on the treatment received and cluster together to be 
separated from other groups.  PCA reduces a multidimensional dataset into, in this case, a 
two dimensional dataset by plotting the first two components that are most important in 
this variance. This program was utilized to determine if groups would cluster according 
to their exposure to different oxygen concentrations and separate in PCA space due to 
different metabolite patterns in the datasets.  
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The spectra were subdivided into 350 regions (bins) and the integrated signal 
intensities were obtained within each bin.  Spectral noise regions were used to determine 
a threshold level to reduce noise fluctuations that can complicate PCA. The mean and 
standard deviation (SD) for the noise bin intensities were calculated for each individual 
spectrum (approximately 100 bins per spectrum), and the threshold value was set at: 
Mean + 3SD.  All bins with values < threshold were then set to zero. The noise regions 
used to calculate the threshold were then removed along with the regions that contain the 
residual water signal at 4.80 ppm.  The intensity of each integrated signal was normalized 
to the sum of all metabolite signal intensities within a spectrum.  This normalizes the data 
for different concentrations of metabolites from sample to sample.  The signal intensities 
were then analyzed using PCA to see if treatment groups would separate.  If separation 
does occur, then the data were further analyzed using Linear Discriminate Analysis 
(LDA), a supervised pattern recognition program.  For LDA, the treatment groups are 
identified and the program determines the importance of each bin in producing a 
separation in the experimental groups.  Each bin is given an LDA weighting factor, which 
enables the bins to be ranked in order of significance. The data is then plotted with the 
first LDA projection against the second LDA projection.  A query of the program then 
lists the bins in order of importance.  This will give information on which peaks are 
changing between treatment groups. 
Once separation of the data is determined with the sum normalization, the data is 
then subjected to another form of normalization.  Bin normalization occurs when the 
mean of each bin across all groups is calculated and it is subtracted from the integral 
within each bin.  This is then divided by the standard deviation from the mean for that 
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bin: (x-mean)/SD.  This normalizes the data so that changes in big peaks are weighted the 
same as small peaks.  PCA is performed on this data set.  If the groups separate, LDA is 
then performed.  This normalization gives information about the most important bins that 
cause the most variance in the data across the groups.  This then directs our attention to 
peaks of importance where there could be differences and those peaks can then be 
integrated to calculate the concentration of each metabolite. 
 
G. Metabolite Quantitative Analysis   
NMR data were processed on a Sun Microsystems computer using Varian 
software (VNMR version 6.1).  The dilution factor was calculated according to Equation 
1.  The saturation factor was calculated according to Equation 2.  Proton and phosphorus 
metabolites and carbon and phospholipid concentrations were determined from each of 
the aqueous and lipid spectra, according to Equations 3-6, respectively.    
DF= Dilution Factor  
SF= Saturation Factor calculated for conversion from a saturated spectrum obtained with                 
T1 saturation and Nuclear Overhouser Effect (NOE) to a fully relaxed spectrum obtained                 
without NOE. 
M= Metabolite of interest 
I= Intensity of peak 
FR= Fully relaxed spectrum 
Sat= Saturated spectrum 
Std= Standard 
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Equation 1: 
DF=
Volume in sample vial (mL)
Volume drawn up from vial  
Equation 2: 
IM
SF=
IStd( )FR
( )SatIMIStd
 
Equation 3: 
ITSP/9
(IM/# of equivalent 1H)( )[Std(mM)] DF Total Volume in NMR tube (mL)[M]1HAQS =
Brain slice weight (g)  
Equation 4: 
IM( )[Std(mM)] DF Total Volume in NMR tube (mL)
[M]31PAQS =
IMDPA
Brain slice weight (g)
SF
 
Equation 5: 
Brain slice weight (g)
IM( )[Std(mM)] DF Total Volume in NMR tube (mL)[M]13CLpd = ICDCL3SF
Equation 6: 
IPC
IM( )[Std(mM)] DF Total Volume in NMR tube (mL)[M]31PLpd =
Brain slice weight (g)  
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H. Statistical Analysis 
Once the concentrations of each metabolite were calculated, statistical analysis 
was performed using JMP version 5.1.2.  ANOVA and Tukey HSD with a p value of 0.05 
set for statistical significance. 
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Chapter IV 
Results 
 
A. Correction Factor for Tissue Sample Weight 
The weight of tissue slices after exposure to hyperbaric oxygen (4.50 ATA) for 60 
minutes are 23% lower in comparison to tissue slices exposed to either 0.40 ATA or 0.95 
ATA O2 at ambient pressure for the same time period (Table I). Whether this is due to an 
effect of oxygen concentration or pressure is unclear. However, an experiment conducted 
at 0.95 ATA O2 and ambient pressure showed that tissue slices exposed for 5 minutes 
yielded weights that were 22% lower than tissues exposed for 60 minutes. Therefore, it 
appears that over time the tissue slices may retain more water. Since the 0.40 ATA and 
0.95 ATA O2 groups measured at 60 minutes yield similar weights, this suggests that 
oxygen concentration is not a factor (at least in this oxygen range). Therefore, we 
hypothesize that water is not retained in the tissue slices of the 4.50 ATA O2 group due to 
pressurization.  
  To test this hypothesis, tissue slices were incubated in 0.95 ATA O2 and 
pressurized using helium gas instead of oxygen.  Briefly, tissue slices (approximately 12 
slices per rat) were prepared and allowed a 1-hour recovery period as described 
previously.  The slices were exposed to a gas mixture at 4.50 ATA containing 76.5% He, 
22.3% O2 and 1.2% CO2 for 60 minutes (full compression achieved in < 5 min). This 
helium mixture allowed for the slices to be exposed to the equivalent of 95% O2 and 5% 
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CO2 for comparison with previous experiments. Following decompression (<5 min) the 
slices were rinsed with saline in a strainer, blotted dry, and frozen in liquid N2 (< 2 
minutes).  Slices from two animals were pooled (~24 slices) to provide a single tissue 
sample, consistent with our previous experimental procedures. The slices were powdered 
with a mortar and pestle under liquid N2 and then transferred into a homogenizer tube to 
determine the weight of each tissue sample.  Weights are expressed as mean ± SD 
(mg/slice).   
TABLE I.  Tissues slice weights for each experimental group (mg per slice, Mean ± SD).  
* Denotes significant difference from 0.40 ATA (ANOVA and Tukey HSD, p≤0.05). 
Weights as a Function of O2 
Concentration 
Weights as a Function 
of Time 
Weights as a Function 
of Pressurized Gas 
0.40 
ATA 
60 min 
0.95 
ATA 
60 min 
4.50 ATA 
60 min  
0.95 
ATA 
60 min 
0.95 ATA 
5 min 
4.50 ATA 
O2
60 min  
4.50 ATA 
He 
60 min  
30.4±5.7 29.8±3.3 
(n=6) 
23.5±2.3 * 
(n=6) 
29.8±3.3 
(n=6) (n=6) 
23.3±3.0 
(n=4) 
23.5±2.3  
(n=6) 
25.6±3.0 
(n=4) 
Calculated Mean Weight per Slice (mg) 
0.95 ATA O2 5 min, 4.50 ATA O2 60 min, 4.50 ATA He 60 min 
24.03±2.7 
 
(n=14) 
 
Table I shows tissue slice weights for each experimental group (mg per slice, 
Mean±SD) as a function of oxygen, time, and pressurized gas.  Comparison by unpaired 
t-test of the samples that were pressurized, HBO group and the hyperbaric helium group 
(HBHe), showed no differences between the weights.  A comparison of all the groups 
that had lower weights, 0.95 ATA O2 at 5 minutes, 4.50 ATA O2, and 4.50 ATA He, 
showed no differences between groups (ANOVA, p≤0.05).  These lower weight groups 
were then combined together and compared to the combination of the two groups with 
greater weight per slice at ambient pressure, namely the 0.40 ATA and 0.95 ATA O2 at 
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60 minutes groups. The weights of the ambient pressure group were significantly greater 
than the pressurized group (t-test, p≤0.05).  It appears that over time the tissue slices 
swell with water, but pressure at 4.50 ATA prevents this swelling independent of whether 
oxygen or helium was used for pressurization.  Therefore, this leads to the conclusion that 
the lower tissue weight is an effect of pressure, but not of oxygen. 
This was then enough evidence to conclude that a correction factor needed to be 
calculated to adjust for the extra weight of water.  The mean of the weight per slice of the 
4.50 ATA O2, 4.50 ATA He, and 0.95 ATA O2 at 5 minutes groups was calculated as 
24.03 mg/slice with a percent standard deviation of 11%.  The number of slices per 
sample was then multiplied by this mean to give the correct amount of brain tissue in 
grams of that sample.  This corrected brain weight was then used to calculate the amount 
of metabolite per gram of tissue for all experimental groups.  
 
B. Principal Component Analyses and Discriminate Analyses 
A PCA scores plot (Figure 7) for slice aqueous metabolites measured by 1H NMR 
shows a separation between experimental groups (A), all O2 levels at 60 min (B), and 
0.95 ATA O2 at 5 and 60 min (C). 
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Figure 7A: PCA scores plot from 1H aqueous spectra. Bright blue lines= 0.40 ATA, 
green lines= 0.95 ATA at 60 min, red lines= 4.50 ATA, dark blue lines=
0.95 ATA at 5 min
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Figure 7B: PCA scores plot from 1H aqueous spectra. Bright blue lines= 0.40 ATA, 
green lines= 0.95 ATA at 60 min, red lines= 4.50 ATA
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Figure 7C: PCA scores plot from 1H aqueous spectra. Bright blue lines= 0.95 ATA at 60 min 
green lines=  0.95 ATA at 5 min
 
These graphs show a plot of principal component 1 (PC1) versus principle 
component 2 (PC2) which are the two most important components that show variance in 
the dataset. These components are plotted against each other and show a separation of the 
groups according to the oxygen treatment that was received.  
Further analysis using LDA (figure 8)  shows separation between all experimental 
groups (A), all groups at 60 minutes (B), and 0.95 ATA O2 at 5 and 60 minutes(C).  
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Figure 8A: LDA projection plot from 1H aqueous spectra. Red lines = 0.40 ATA, 
blue lines = 0.95 ATA at 60 min, green lines = 4.50 ATA, 
aqua lines= 0.95 ATA at 5 min
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Figure 8B: LDA projection plot from 1H aqueous spectra. Red lines = 0.40 ATA, 
blue lines = 0.95 ATA at 60 min, green lines = 4.50 ATA
 
Figure 8C: LDA projection plot from 1H aqueous spectra. Red lines = 0.95 ATA at 60 min, 
blue lines= 0.95 ATA at 5 min
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These graphs show a plot of LDA projection 1 versus LDA projection 2.  Since 
the program knows the identification of the groups, it tries to separate according to 
differing profiles between the groups.  These graphs show that there was separation 
between the experimental groups. A query of the program gave a list of LDA weighting 
factors (coefficients) and identified the spectral regions (bins or PPM values) that cause 
the separation (Table II).  This list was then used as a guide to look at different 
metabolites within the spectra.   
 
TABLE II. Highest ranked 1H aqueous LDA weighting factors, PPMs, and identified    
metabolites. 
1H Aqueous Linear Discriminate Analysis 
Weighting  
Factor 
PPM Metabolite Corresponding 1H Multiplicity 
-0.1566 1.32 Lactate 3CH3 Doublet 
 0.1563 3.96 Creatine and 
Phosphocreatine 
(Cr and PCr) 
2CH2 Singlet 
-0.1502 4.12  Lactate 2CH Quartet 
 0.1186 2.36 Pyruvate 3CH3 Singlet 
 0.1151 4.40 N-acetylaspartate 
(NAA) 
2CH Doublet of 
doublet 
-0.1134 1.88 Acetate 2CH3 Singlet 
 
C. Metabolite Analyses from 1H Aqueous Spectra 
Figure 9 is a graph of some of the quantified (μmol/g tissue, Mean±SE) salient 
metabolites identified from LDA.  N-acetylaspartate (NAA) shows no differences across 
all 60 minute time point groups. Acetate was elevated in 0.40 ATA O2 group by 80% 
compared to the 4.50 ATA O2 group.  Pyruvate showed no differences between 60 minute 
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time point groups, but for lactate the 4.50 ATA O2 group was significantly lower 
compared to both 0.95 ATA O2 at 60 minutes (60%) and 0.40 ATA O2 (73%).   
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Figure 9: Quantified 1H aqueous metabolites (umol/g tissue,Mean±SE). Filled black bars= 0.40 ATA O2,
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
* denotes significant difference from 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05).
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Figure 10 shows a comparison of 0.95 ATA O2 groups at different time points, 60 
minutes and 5 minutes.  NAA and pyruvate were significantly lower in the 0.95 ATA O2 
at 60 minutes group compared to the 0.95 ATA O2 at 5 minutes group.  No differences 
were found for acetate or lactate between these groups. 
 28
um
ol
/g
tis
su
e
Figure 10: Quantified 1H aqueous metabolites (umol/g tissue, Mean±SE)
White polka dot bars=0.95 ATA O2 at 60 minutes, filled white bars=0.95 ATA O2
at 5 minutes
* denotes significant difference from 0.95 ATA O2 at 5 minutes (t-test,  p≤.05).
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D. Metabolite Analyses from 31P Aqueous Spectra 
Figure 11 shows phosphorus metabolites that can be identified from the 31P 
spectra.  Dihydroxyacetone phosphate (DHAP) showed no differences between groups.  
Glycerol-3-phosphate (G3P) showed that 0.40 ATA O2 group and 0.95 ATA O2 group 
were not different, but that they were both about a 5-fold increase over the 4.50 ATA O2 
group. 
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Figure 11: Quantified 31P aqueous metabolites (umol/g tissue,Mean±SE). Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
* denotes significant difference from 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05).
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E. Metabolite Ratios 
Figure 12 shows metabolite ratios of G3P/DHAP and lactate/pyruvate.  The 4.50 
ATA O2 group is significantly lower than both the 0.40 ATA and 0.95 ATA O2 at 60 
minute groups (78%) with respect to G3P/DHAP ratio. With respect to the 
lactate/pyruvate ratio, the 4.50 ATA O2 group is significantly lower than the 0.40 ATA 
(71%) and 0.95 ATA O2 groups (65%). 
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Figure 12: Metabolite ratios from 31P and 1H aqueous spectra. Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
* denotes significant difference from 0.40 ATA O2 and 0.95 ATA O2 (ANOVA, Tukey HSD p≤.05).
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Figure 13 illustrates a correlation between O2 concentration and the G3P/DHAP and the 
lactate/pyruvate ratios.  Both of these metabolite ratios decrease with increasing oxygen 
concentration, and the data fit a linear correlation fairly well (r2=0.95). 
R2 = 
0
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0.0 1.0 2.0 3.0 4.0 5.0
[O2] 
G3P/DHAP
Lactate/Pyruvate
.9468
Figure 13: Ratios of G3P/DHAP and Lactate/Pyruvate plotted per oxygen concentration. 0.40 ATA 
0.95 ATA, and 4.50 ATA O2
 
 
  Figure 14 shows high energy phosphate metabolites from the 31P spectra.  The 
Adenosine triphosphate (ATP) showed no differences across groups, but the 4.50 ATA 
O2 phosphocreatine (PCr) was greater compared to both 0.40 ATA (153%) and 0.95 ATA 
O2 (82%), although there were no differences in inorganic phosphate (Pi, Figure 15).   
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Figure 14: Quantified 31P aqueous metabolites (umol/g tissue,Mean±SE). Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
* denotes significant difference from 0.40 ATA O2 and 0.95 ATA O2 (ANOVA, Tukey HSD p≤.05)
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Figure 15: Quantified 31P aqueous metabolites (umol/g tissue, Mean±SE). Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
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Figure 16 shows high energy phosphate ratios from the phosphorus aqueous 
spectra.  The 0.40 ATA O2 group is lower than both the 0.95 ATA O2 and 4.50 ATA O2 
groups for PCr/ATP.  The ATP/Pi ratio for the 4.50 ATA O2 group is greater than both 
the 0.40 ATA and 0.95 ATA O2 groups.    
 
Figure 16: Metabolite ratios from 31P aqueous spectra. Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
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*denotes significant difference from 0.95 ATA O2 and 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05)
‡denotes significant difference from 0.40 ATA O2 and 0.95 ATA O2 (ANOVA, Tukey HSD p≤.05)
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Figure 17 shows phosphorous metabolites involved in phospholipid synthesis and 
degradation pathways.  The 4.50 ATA O2 group phosphoethanolamine (Petn) was 66% 
lower compared to 0.40 ATA O2 group.  There were no differences seen between groups 
with phosphocholine (Pcho), glycerophosphoethanolamine (GPE), or 
glycerophosphocholine (GPC). 
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Figure 17: Quantified 31P aqueous metabolites (umol/g tissue,Mean±SE). Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
* denotes significant difference from 0.40 ATA O2 (ANOVA, Tukey HSD p≤.05).
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F. Metabolite Analyses from 31P Lipid Spectra 
Figure 18 shows the quantification of phospholipids from the 31P lipid spectra.  
The 0.40 ATA O2 phosphatidylinositol (PI) is 60% greater than the 4.50 ATA O2.  
Cardiolipin (CL) was also greater by 65% in 0.40 ATA O2 compared to 4.50 ATA O2.  
There were no significant differences in Phosphatidylethanolamine, Sphingomyelin, 
Phosphatidylserine, Choline plasmalogen, or Phosphatidylcholine. There were no 
significant differences in Phosphoatidylethanolamine plasmalogen or phosphatidic acid, 
but they did show a trend to decrease with increasing oxygen concentration (Table III). 
 
Figure 18: Quantified 31P lipids (umol/g tissue,Mean±SE). Filled black bars= 0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
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* denotes significant difference from 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05).
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TABLE III. Quantified 31P phospholipids (μmol/ g tissue, Mean ± SE). 
Phosphorus Lipid Quantitation 
 
0.40 ATA 
(n=5) 
0.95 ATA 60 
min (n=6) 
4.50 ATA 
(n=6) 
Phosphatidylethanolamine plasmalogen  
(PE pls) 7.23 ± 0.76 6.40 ± 0.35 5.24 ± 0.45 
Phosphatidylinositol (PI) 
0.70 ± 0.09 
* 0.55 ± 0.04 0.44 ± 0.06 
Cardiolipin (CL) 
0.53 ± 0.08 
* 0.48 ± 0.03 0.32 ± 0.03 
Phosphatidic Acid (PA) 0.35 ± 0.05 0.29 ± 0.02 0.22 ± 0.02 
 * denotes significant difference from 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05) 
 
 
G. Metabolite Analyses from 13C Lipid Spectra 
TABLE IV. Carbon lipid peaks and respective PPM. 
13Carbon Lipid Metabolites 
PPM Metabolite 
141.3 Cholesterol carbon 5 
12.3 Cholesterol carbon 18 
54.6 Phosphatidylcholine 
21.0 Omega-3 Fatty Acids 
69.1 Triacylglycerides 
 
Figure 19 shows the quantification of carbon lipids from the 13C lipid spectra.  
There were no differences between groups at 60 minutes for cholesterol and 
triacylglycerides, but both trend toward a decrease with increasing oxygen.  Omega-3 
fatty acids show a significant decrease from 0.40 ATA O2 group to 4.50 ATA O2 group 
with the same decreasing trend with increasing oxygen. 
 
 37
um
ol
/g
tis
su
e
Figure 19: Quantified 13C lipids (umol/g tissue,Mean±SE). Filled black bars=0.40 ATA O2, 
white polka dot bars=0.95 ATA O2 at 60 minutes, black hatched bars=4.50 ATA O2
*
* denotes significant difference from 4.50 ATA O2 (ANOVA, Tukey HSD p≤.05).
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H. Time Dependence of Metabolite Ratios  
Table V shows a comparison of metabolite ratios for 0.95 ATA O2 at 60 minutes 
vs. 5 minutes.  Significant differences were found for Lactate/Pyruvate, G3P/DHAP, 
Petn/PE, Petn/PE Pls, and Petn/GPE.  
TABLE V. Metabolite Ratios (Mean ± SE). 
Metabolite Ratios for 0.95 ATA O2 60 minutes vs. 5 minutes 
 0.95 ATA 60 min 
(n=6) 
0.95 ATA 5 min 
(n=4) 
Lactate/Pyruvate 3.62 ± 0.30 * 1.88 ± 0.15 
PCr/ATP 1.66 ± 0.16 2.08 ± 0.20 
ATP/Pi 0.08 ± 0.01 0.06 ± 0.01 
G3P/DHAP 3.61 ± 0.38 * 1.30 ± 0.21 
Petn/PE 8.50 ± 1.50 * 20.04 ± 0.34 
Petn/PE Pls 6.34 ± 1.04 * 14.56 ± 0.29 
Petn/GPE 0.12 ±  0.02 * 0.26 ± 0.01 
* denotes significant difference from 0.95 ATA O2 at 5 minutes (t-test, p≤.05) 
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Chapter V 
Discussion 
A. PCA and LDA Analysis 
Separation between experimental groups using PCA scores plots for 1H NMR 
suggests that the tissue metabolite profile changes are induced by O2 (Figure 7).  This 
was further examined by using LDA to identify salient metabolites that caused the 
separation (Figure 8).  The metabolite list generated was further examined by quantifying 
metabolites from the spectra and comparing each group (Table II).  
 
B. Neuronal Cell Viability      
NMR measurements of chemical extracts provide a metabolite profile from the 
entire tissue slice and cannot discern glial from neuronal cell types.  However, N-
acetylaspartate (NAA) is a marker of neuronal cell viability and can be quantified.  
This will show whether the neuron population, which is sensitive to oxygen 
concentration, is dying. There were no differences in NAA, which suggests that these 
oxygen concentrations did not adversely affect the neurons (Figure 9).  But, overall tissue 
metabolism showed differences in response to O2 concentrations. 
 
C. Oxygen Effects on Energy Metabolism 
By examining the 1H spectra, insight can be gained into the function of glycolysis 
and the TCA cycle (Figure 9).  Acetate and Lactate were both elevated in the 0.40 ATA 
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O2 group.  This may be indicative of a hypoxic environment and the cells are using 
anaerobic glycolysis to generate ATP through lactate and the acetate is elevated because 
it is not used to make acetyl-CoA for input into the TCA cycle.  Lactate is also lower in 
4.50 ATA O2 where oxidative phosphorylation is running well because there is an 
abundance of oxygen.  There were no differences in pyruvate between all groups.  This 
could be because it is being utilized in the 4.50 ATA O2 group in the TCA cycle and 
being converted to lactate in 0.40 ATA O2 group.   
The increase in NAA and pyruvate in the 0.95 ATA O2 at 60 minutes compared to 
the 0.95 ATA O2 at 5 minutes (Figure 10) may be the result of the tissue damage caused 
by slicing.  During the recovery and treatment period, the membranes of the cells repair 
themselves so there is increased metabolism and use of pyruvate to generate ATP.  The 
stores may be replenished during the 60 minute treatment period resulting in more 
pyruvate at the 60 minute time point compared to the 5 minute time point. 
Examining the 31P aqueous spectra gives insight into the energy metabolism of the 
slices and supports the previous conclusions about oxidative phosphorylation.  ATP and 
PCr both are elevated in 4.50 ATA O2 group and Pi trends to being lower, but is not 
significant (Figure 14 and Figure 15).  This suggests that the tissue slices have a good 
energy status.  The PCr/ATP ratio (Figure 16) is the same as reported in vivo in humans 
at 2.1 ± 0.13 [41-43]  This strengthens the conclusion that oxidative phosphorylation is 
running well in 4.50 ATA O2 group, which is hyperoxic, and that 0.40 ATA O2 may be 
becoming hypoxic.  In this same spectra, peaks for DHAP and G3P can be examined that 
will give insight into the cytosolic redox potential of the cells (Figure 11).  There were no 
changes in DHAP, but G3P was lower in 4.50 ATA O2 group than the other 60 minute 
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exposure groups.  When ratios of G3P/DHAP and Lactate/Pyruvate are examined, both 
ratios are lower in 4.50 ATA O2 group compared to the other 60 minute exposure groups 
(Figure 12).  These metabolites are both involved in NAD+ linked dehydrogenase 
reactions.  A correlation to oxygen concentration can also be seen with the ratios (Figure 
13) so the ratios seem to be linked to the concentration of oxygen.  This can give insight 
into the equilibrium status of the dehydrogenase reaction.  It shows that the 0.40 ATA O2 
group may be hypoxic.  The lactate and G3P levels are elevated so the NAD+/NADH 
ratio could be low (Figure 20).   
 
 
Figure 20: Glycolytic pathway and TCA cycle affected by 0.40 ATA O2. 
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This would agree with a study by Ben-Yoseph et al. that showed elevated G3P and 
NADH/NAD+ ratios in male Hartley guinea pig cerebral cortex slices exposed to severe 
hypoxia [44].  Also in the 4.50 ATA O2 group, it shows that it is highly oxidized and 
there could be an elevated NAD+/NADH ratio.  The cells may use oxidative 
phoshorylation and shuttle mechanisms from the cytosol to the mitochondrion to try to 
eliminate the toxic concentrations of oxygen by converting it to water within the electron 
transport chain.  One such shuttle mechanism, the Malate-Aspartate Shuttle, uses 
NAD+/NADH to transfer reducing equivalents from the cytosol to the mitochondrion 
(Figure 21).  In the mitochondrion, this shuttle converts malate to oxaloacetate while 
NAD+ is reduced to NADH.  The reoxidation of NADH by the ETC allows the flow of 
electrons to drive ATP synthesis.  In that process, O2 get reduced to H2O.  This shuttle is 
considered the most important shuttle in the brain [45]. 
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Figure 21: Glycolytic pathway and TCA cycle affected by 4.50 ATA O2. 
 
 
D. Phospholipid Synthesis and Degradation  
By studying the peaks in the 31P aqueous and lipid spectra, phospholipid synthesis 
and degradation pathways can be examined (Figure 17).  Phosphoethanolamine (Petn) 
was found to be lower with increasing oxygen.  There was significantly lower amount in 
the 4.50 ATA O2 group than the 0.40 ATA O2 group.  A recent study showed that when 
high amounts of Petn are given exogenously to isolated mitochondria that electron 
transfer activity is inhibited [46].  So the increased amounts found in the 0.40 ATA O2 
group may impair mitochondrial function which may change slice metabolism.  There 
were no differences in Glycerophosphoethanolamine (GPE) or Phosphatidylethanolamine 
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(PE) between groups.  Since there were no other significant changes in these other lipids 
in the pathway, it could suggest that there is an effect on the lipid converting enzymes 
involved in the pathway, such as Ethanolamine kinase that converts ethanolamine to 
phosphoethanolamine or CTP: phosphoethanolamine cytidyl transferase that converts 
phosphoethanolamine to CDP-ethanolamine.  Oxygen concentrations or ROS could have 
an effect on these enzymes although this has not been reported in the literature.  It seems 
that PE biosynthesis is inhibited, but the PE concentration remains constant over all O2 
groups.  PE can also be made by decarboxylation of PS, not just through the Kennedy 
pathway.   There were no differences found in the phosphatidylcholine synthesis and 
degradation pathways though.  Phosphatidylinositol (PI) and Cardiolipin (CL) were both 
found to be significantly lower in 4.50 ATA O2 (Figure 18).  Cardiolipin is primarily 
present in the inner mitochondrial membrane and very susceptible to peroxidation.  
Losses of cardiolipin in cultured rat neurons have been shown and those losses were due 
to oxidative damage caused by lipid peroxidation [47].  Morin et al. showed that ROS 
produced during in vitro reoxygenation studies of rat brain mitochondria is responsible 
for cardiolipin peroxidation [48].  The elevated oxygen concentrations may be causing 
peroxidation, which may lead to alterations in the mitochondria and how they function.  
A review of the role of cardiolipin in oxidative phosphorylation suggests that the 
headgroup may buffer protons in the electron transport chain (ETC) and may act as a 
regulator.  This is so the ETC will not run out of control.  This review suggests that when 
there is less cardiolipin that the basal metabolic rate increases [49] [50].  This may be 
why we also see increased levels of ATP in the 4.50 ATA O2 group because there is less 
cardiolipin to regulate the ETC.   There were no differences in PA or PE pls, which is 
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surprising knowing that it has been shown that plasmalogens can protect against an 
oxidative insult as shown in rat brain with phosphine-induced oxidative stress [39].  
There was a trend that showed that PE pls and PA decreased with increasing oxygen 
concentration, although this was not significant (Table III). 
 
E. Effects of Oxygen on Lipids 
Lipids were also examined from the 13C spectra (Figure 19).  Cholesterol and 
triacylglycerides (TAG) showed a trend that with increasing oxygen there was less of 
each, although this was not significant.  The Omega-3 FA was significantly lower when 
exposed to 4.50 ATA O2 than with 0.40 ATA O2.  Both Omega-3 FA and cardiolipin are 
polyunsaturated fatty acids and were significantly lower in the 4.50 ATA O2 group 
compared to the 0.40 ATA O2 group.  The increased amount of ROS at higher oxygen 
concentrations may cause lipid peroxidation and thus result in a lower amount of both of 
these lipids.   
Metabolite ratios were compared between the 0.95 ATA O2 group at 60 minutes 
and the 0.95 ATA O2 group at 5 minutes (Table V).  These were examined to see if there 
were differences over time instead of oxygen concentration.   There was a significant 
increase in both lactate/pyruvate and G3P/DHAP over time.  There is a shift in these 
metabolite ratios due to the oxidized forms of these metabolites being used to repair the 
cell membranes in the tissue slice.  The Petn/PE, Petn/ PE pls, and Petn/GPE ratios all 
significantly decrease from the 5 minute to the 60 minute time point.  It suggests that 
there is a loss of PE during slicing due to membrane rupture.  The precursor in the 
biosynthetic pathway is Petn.  Since there is a loss of PE the Petn/PE ratio is higher at 5 
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minutes than at 60 minutes when the membranes have repaired themselves.  PE is also 
the precursor of PE pls and GPE. So the Petn/PE pls and Petn/GPE ratios are also lower 
at 60 minutes.  By the 60 minute time point, the ratios are lower because the biosynthetic 
pathways are again using Petn for PE, PE pls, and GPE synthesis.    
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Chapter VI 
Conclusions 
 These experiments have demonstrated that brain tissue slice metabolism can be 
affected by different doses of oxygen.  They suggest that 0.40 ATA O2 may make the 
tissue hypoxic and therefore shift metabolism toward anaerobic glycolysis to generate 
ATP.  The reduced environment due to the low oxygen suggests a low NAD+/NADH 
which explains the elevated lactate and G3P.  It also explains the low PCr/ATP.  The 
elevated Petn could also inhibit electron transport activity to further reduce the energy 
status of the slices. 
  The results also suggest that high doses of oxygen may cause aerobic glycolysis 
and oxidative phosphorylation to accelerate.  The environment is very oxidized which 
may mean an elevated NAD+/NADH and explains the lower lactate and G3P amounts 
and higher PCr/ATP ratio.  The lower polyunsaturated FA amounts may be caused by 
increased ROS which may cause lipid peroxidation with cardiolipin and omega-3 FA.  
Lower cardiolipin amounts may cause the deregulation of the ETC.  But the increase in 
superoxide shown by Dr. Dean and lower cardiolipin amounts found here suggest 
mitochondrial damage.  The NAA amounts remained the same across all O2 groups and 
suggest no neuronal damage and the energy status of the slices seems good.  It may be 
very early damage and the effects have yet to fully develop. 
The 0.40 ATA O2 results suggest a hypoxic environment while the 0.95 and 4.50 
ATA O2 results suggest hyperoxic environments that lead to changes in metabolism on 
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both ends of the oxygen spectrum.  These results suggest that an oxygen concentration 
between 0.40 ATA and 0.95 ATA for tissue slice work would reduce the changes in 
metabolism and mimic that which is found in vivo. 
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APPENDIX A 
 
 
Quantitation Data Tables 60 Minute Timepoint 
Lipids from 
Carbon 
Spectra   n=5 n=6 n=6 
 
Signal 
PPM 
Saturation 
Factor 0.40 ATA 0.95 ATA 60 min 4.50 ATA 
   Mean ± SE Mean ± SE Mean ± SE 
Chol C5 and 
C18 
C5-141.3    
C18-12.3 
C5-0.064  
C18-0.029 20.6 ± 1.8 19.33 ± 1.2 15.9 ± 1.5 
w-3 C2 21 0.076 6.64 ± 0.74 5.72 ± 0.30 4.44 ± 0.51 * 
TAG 69.1 0.038 3.63 ± 0.57 2.72 ± 0.28 2.34 ± 0.37 
Chol C6 122.1 0.024 16.31±1.75 16.14±1.09 13.06±1.07 
PC 54.4 0.024 11.77±1.27 10.84±0.58 8.93±0.78 
      
Phospholipids   n=5 n=6 n=6 
   0.40 ATA 0.95 ATA 60 min 4.50 ATA 
PC -0.84 0.024 11.77±1.27 10.84±0.58 8.93±0.78 
PE 0.02  5.2±0.58 4.84±0.30 4.07±0.42 
PS -0.18  3.32±0.36 2.99±0.19 2.52±0.27 
SM -0.06  1.13±0.11 1.03±0.07 0.90±0.10 
Choline Pls -0.78  0.27±0.05 0.24±0.02 0.25±0.05 
unknown 0.12  0.23±0.06 0.22±0.02 0.15±0.02 
PE pls 0.08  7.23 ± 0.76 6.40 ± 0.35 5.24 ± 0.45 
PI -0.4  0.70 ± 0.09 0.55 ± 0.04 0.44 ± 0.06 * 
CL 0.16  0.53 ± 0.08 0.48 ± 0.03 0.32 ± 0.03 * 
PA 0.22  0.35 ± 0.05 0.29 ± 0.02 0.22 ± 0.02 
* denotes significant difference from 0.40 ATA O2 (ANOVA, Tukey HSD p≤.05) 
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Quantitation Data Tables 60 Minute Timepoint 
Metabolites from Proton 
Aqueous Spectra   n=6 n=6 n=6 
 
Signal 
PPM 
Saturation 
Factor 0.40 ATA 0.95 ATA 60 min 4.50 ATA 
NAA 4.4  4.60 ± 0.53 3.74 ± 0.22 4.16 ± 0.52 
Myo-inositol 4.04  4.16±0.49 3.44±0.26 3.33±0.39 
Cr & PCr 3.96  5.53 ± 0.67 4.73 ± 0.21 4.90 ± 0.52 
Aspartate 3.88  1.03±0.13 0.98±0.09 1.07±0.15 
Pyruvate 2.36  .88 ± 0.12 0.76 ± 0.06 1.03 ± 0.12 
Acetate 1.88  1.73 ± 0.20 1.25 ± 0.09 0.96 ± 0.08 * 
Lactate 4.12  12.14 ± 1.7 8.26 ± 0.95 3.37 ± 0.45 ‡ 
      
Metabolites from 
Phosphorus Aqueous 
Spectra   n=5 n=6 n=6 
   0.40 ATA 0.95 ATA 60 min 4.50 ATA 
DHAP 7.9 1.071 0.12 ± 0.02 0.12 ± 0.01 0.12 ± 0.04 
G3P 7.5 1.061 0.50 ± 0.03 0.44 ± 0.06 0.10 ± 0.01 ‡ 
ATP -18.2 0.723 0.39 ± 0.03 0.36 ± 0.04 0.51 ± 0.05 
PCr 0 0.815 0.43 ± 0.06 0.59 ± 0.07 1.08 ± 0.12 ‡ 
Petn 6.9 0.736 0.23 ± 0.01 0.10 ± 0.05 0.08 ± 0.03 * 
Pcho 6.5 1.064 0.18 ± 0.2 0.19 ± 0.02 0.16 ± 0.01 
GPE 3.7 1.737 0.18 ± 0.02 0.20 ± 0.01 0.20 ± 0.02 
GPC 3 1.08 0.25 ± 0.02 0.29 ± 0.02 0.32 ± 0.03 
NAD(H) -8.5 0.402 0.06 ± 0.0 0.06 ± 0.01 0.06 ± 0.01 
Pi 5.5 1.691 4.15 ± 0.26 4.62 ± 0.39 3.50 ± 0.31 
* denotes significant difference from 0.40 ATA O2 (ANOVA, Tukey HSD p≤.05) 
‡ denotes significant difference from 0.40 and 0.95 ATA O2 (ANOVA, Tukey HSD     
    p≤.05) 
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Ratios 60 Minute Timepoint 
Ratios n=6 n=6 n=6 
 0.40 ATA 0.95 ATA 60 min 4.50 ATA 
NAA/Creatine 0.40±0.01 0.39±0.01 0.39±0.01 
Lactate/Creatine 1.03±0.05 0.84±0.08 0.38±0.05 
Myo-inositol/Creatine 0.35±0.01 0.34±0.02 0.31±0.01 
Lactate/Pyruvate 4.36 ± 0.30 3.62 ± 0.30 1.26 ± 0.12 ‡ 
Pyruvate/Creatine 0.22±0.01 0.23±0.01 0.29±0.02 
PCr/ATP 1.12 ± 0.12§  1.66 ± 0.16 2.11 ± 0.13  
ATP/Pi 0.09 ± 0.01 0.08 ± 0.01 0.15 ± 0.02 ‡ 
G3P/DHAP 5.08 ± 0.85 3.61 ± 0.38 0.94 ± 0.13 ‡ 
Petn/PE 6.35 ± 0.76 8.50 ± 1.50 11.13 ± 1.76 
Petn/PE Pls 4.57 ± 0.56 6.34 ± 1.04 8.48 ± 1.25 
Petn/GPE 0.08 ± 0.01 0.12 ± 0.02 0.15 ± 0.02 
‡ denotes significant difference from 0.40 and 0.95 ATA O2 (ANOVA, Tukey HSD     
    p≤.05) 
§ denotes significant difference from 0.95 and 4.50 ATA O2 (ANOVA, Tukey HSD     
    p≤.05) 
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APPENDIX B 
 
 
Quantitation Data Tables 0.95 ATA   5 and 60 Minute Timepoints 
Lipids from Carbon 
Spectra   n=4 n=6 
 Signal PPM 
Saturation 
Factor 0.95 ATA 5 min 0.95 ATA 60 min 
   Mean ± SE Mean ± SE 
Chol C5 and C18 
C5-141.3     
C18- 12.3 
C5-0.064  
C18-0.029 17.62 ± 1.2 19.33 ± 1.2 
w-3 C2 21 0.076 5.48 ± 0.50 5.72 ± 0.30 
TAG 69.1 0.038 2.44 ± 0.19 2.72 ± 0.28 
Chol C6 122.1 0.024 14.04±0.93 16.14±1.09 
PC 54.4 0.024 9.80±0.59 10.84±0.58 
     
Phospholipids   n=4 n=6 
   0.95 ATA 5 min 0.95 ATA 60 min 
PC -0.84 0.024 9.80±0.59 10.84±0.58 
PE 0.02  4.24±0.23 4.84±0.30 
PS -0.18  2.74±0.13 2.99±0.19 
SM -0.06  0.97±0.03 1.03±0.07 
Choline Pls -0.78  0.28±0.01 0.24±0.02 
unknown 0.12  0.25±0.05 0.22±0.02 
PE pls 0.08  5.85 ± 0.38 6.40 ± 0.35 
PI -0.4  0.48 ± 0.03 0.55 ± 0.04 
CL 0.16  0.47 ± 0.05 0.48 ± 0.03 
PA 0.22  0.27 ± 0.02 0.29 ± 0.02 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56
 
 
Quantitation Data Tables 0.95 ATA   5 and 60 Minute Timepoints 
Metabolites from Proton 
Aqueous Spectra   n=4 n=6 
 
Signal 
PPM 
Saturation 
Factor 0.95 ATA 5 min 0.95 ATA 60 min 
NAA 4.4  4.83 ± 0.41 3.74 ± 0.22 ¥ 
Myo-inositol 4.04  4.21±0.21 3.44±0.26 
Cr & PCr 3.96  5.68 ± 0.41 4.73 ± 0.21 
Aspartate 3.88  1.37±0.06 0.98±0.09 
Pyruvate 2.36  1.28 ± 0.08 0.76 ± 0.06 ¥ 
Acetate 1.88  1.00 ± 0.04 1.25 ± 0.09 
Lactate 4.12  7.42 ± 0.88 8.26 ± 0.95 
     
Metabolites from Phosphorus 
Aqueous Spectra   n=4 n=6 
   0.95 ATA 5 min 0.95 ATA 60 min 
DHAP 7.9 1.071 0.15 ± 0.03 0.12 ± 0.01 
G3P 7.5 1.061 0.18 ± 0.03 0.44 ± 0.06 ¥ 
ATP -18.2 0.723 0.29 ± 0.05 0.36 ± 0.04 
PCr 0 0.815 0.60 ± 0.09 0.59 ± 0.07 
Petn 6.9 0.736 0.05 ± 0.01 0.10 ± 0.05 
Pcho 6.5 1.064 0.16 ± 0.02 0.19 ± 0.02 
GPE 3.7 1.737 0.21 ± 0.02 0.20 ± 0.01 
GPC 3 1.08 0.27 ± 0.03 0.29 ± 0.02 
NAD(H) -8.5 0.402 0.06 ± 0.01 0.06 ± 0.01 
Pi 5.5 1.691 5.19 ± 0.56 4.62 ± 0.39 
¥ denotes significant difference from 0.95 ATA O2 at 5 min (ANOVA, Tukey HSD  
    p≤.05) 
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Quantitation Data Tables 0.95 ATA   5 and 60 Minute Timepoints 
Ratios n=4 n=6 
 0.95 ATA 5 min 0.95 ATA 60 min 
NAA/Creatine 0.38±0.0 0.39±0.01 
Lactate/Creatine 0.6±0.05 0.84±0.08 
Myo-inositol/Creatine 0.33±0.01 0.34±0.02 
Lactate/Pyruvate 1.88 ± 0.15 3.62 ± 0.30 ¥ 
Pyruvate/Creatine 0.31±0.0 0.23±0.01 
PCr/ATP 2.08 ± 0.20 1.66 ± 0.16 
ATP/Pi 0.06 ± 0.01 0.08 ± 0.01 
G3P/DHAP 1.30 ± 0.21 3.61 ± 0.38 ¥ 
Petn/PE 20.04 ± 0.34 8.50 ± 1.50 ¥ 
Petn/PE Pls 14.56 ± 0.29 6.34 ± 1.04  ¥ 
Petn/GPE 0.26 ± 0.01 0.12 ± 0.02 ¥ 
¥ denotes significant difference from 0.95 ATA O2 at 5 min (ANOVA, Tukey HSD  
    p≤.05) 
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